These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2483600)

  • 1. [New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow].
    Kusowska J; Polakowski P
    Acta Pol Pharm; 1989; 46(2):187-94. PubMed ID: 2483600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ; Ruo TI; Piergies AA
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
    Singh BN; Feld G; Nademanee K
    Angiology; 1986 Dec; 37(12 Pt 2):930-8. PubMed ID: 2433967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of N-acetylprocainamide in man: comparison with other antiarrhythmic drugs.
    Josephson MA; Singh BN
    Angiology; 1986 Dec; 37(12 Pt 2):950-8. PubMed ID: 2433969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog.
    Bagwell EE; Walle T; Drayer DE; Reidenbert MM; Pruett JK
    J Pharmacol Exp Ther; 1976 Apr; 197(1):38-48. PubMed ID: 1263131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new anti-arrhythmia drug. I. Study of the anti-arrhythmia effects of a new N-acyl derivative of procainamide in rabbits].
    Kusowska J
    Acta Pol Pharm; 1988; 45(4):346-50. PubMed ID: 3245471
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
    Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
    Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of the hemodynamic effects of procainamide and N-acetylprocainamide in rabbits].
    Matusewicz W
    Kardiol Pol; 1984; 27(5):393-400. PubMed ID: 6208404
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ; Ruo TI
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].
    Matusewicz W; Orszulak DE
    Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic and electrocardiographic studies of the interaction of N-acetylprocainamide and procainamide with digoxin in rabbits].
    Matusewicz W
    Kardiol Pol; 1984; 27(5):401-7. PubMed ID: 6208405
    [No Abstract]   [Full Text] [Related]  

  • 16. Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1990 May; 39(5):720-40. PubMed ID: 1693889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):851-62. PubMed ID: 6164783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias.
    Atkinson AJ; Lertora JJ; Kushner W; Chao GC; Nevin MJ
    Clin Pharmacol Ther; 1983 May; 33(5):565-76. PubMed ID: 6188570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent.
    Drayer D; Kluger J; Reidenberg M; Lahita R
    Drug Metab Rev; 1979; 10(2):239-46. PubMed ID: 95247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part I. Propofol anesthesia.
    Orszulak-Michalak D
    Pol J Pharmacol; 1995; 47(2):143-52. PubMed ID: 8688887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.